mutLBSgeneDB |
Gene summary for CRP |
Gene summary |
Basic gene Info. | Gene symbol | CRP |
Gene name | C-reactive protein, pentraxin-related | |
Synonyms | PTX1 | |
Cytomap | UCSC genome browser: 1q23.2 | |
Type of gene | protein-coding | |
RefGenes | NM_000567.2, | |
Description | C-reactive proteinpentraxin 1 | |
Modification date | 20141222 | |
dbXrefs | MIM : 123260 | |
HGNC : HGNC | ||
Ensembl : ENSG00000132693 | ||
HPRD : 00422 | ||
Vega : OTTHUMG00000035344 | ||
Protein | UniProt: P02741 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_CRP | |
BioGPS: 1401 | ||
Pathway | NCI Pathway Interaction Database: CRP | |
KEGG: CRP | ||
REACTOME: CRP | ||
Pathway Commons: CRP | ||
Context | iHOP: CRP | |
ligand binding site mutation search in PubMed: CRP | ||
UCL Cancer Institute: CRP | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0010628 | positive regulation of gene expression | 24141169 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation | 18322245 | GO:0010888 | negative regulation of lipid storage | 18322245 | GO:0032930 | positive regulation of superoxide anion generation | 24141169 | GO:0045908 | negative regulation of vasodilation | 24141169 | GO:2000482 | regulation of interleukin-8 secretion | 21037097 |
Top |
Ligand binding site mutations for CRP |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | S92 | Y91F | LUAD | 1 | E156 | E156V | LUSC | 1 | D78 | R76K | SKCM | 1 | N163 | N163Y | STAD | 1 | D158 | D158N | STAD | 1 | Q168 | S169P | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for CRP |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | S92 | Y91F | -1.23779 | D158 | D158N | -1.0235748 | Q168 | S169P | -0.83153747 | D78 | R76K | -0.72951087 | N163 | N163Y | -0.19161875 | E156 | E156V | -0.17686015 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for CRP from PDB |
Top |
Differential gene expression and gene-gene network for CRP |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for CRP |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0007222 | Cardiovascular Diseases | 135 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0004153 | Atherosclerosis | 91 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0003873 | Arthritis, Rheumatoid | 61 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0524620 | Metabolic Syndrome X | 36 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0020538 | Hypertension | 35 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0021368 | Inflammation | 32 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0024141 | Lupus Erythematosus, Systemic | 23 | Biomarker, GeneticVariation |
umls:C0948089 | Acute Coronary Syndrome | 16 | Biomarker, GeneticVariation |
umls:C0151744 | Myocardial Ischemia | 14 | Biomarker, GeneticVariation |
umls:C2239176 | Carcinoma, Hepatocellular | 13 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0010346 | Crohn Disease | 11 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0018799 | Heart Diseases | 10 | Biomarker, GeneticVariation |
umls:C0018801 | Heart Failure | 8 | Biomarker |
umls:C3714514 | Infection | 7 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0031099 | Periodontitis | 7 | Biomarker |
umls:C0022661 | Kidney Failure, Chronic | 6 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0024530 | Malaria | 6 | Biomarker, GeneticVariation |
umls:C0025517 | Metabolic Diseases | 5 | Biomarker, GeneticVariation |
umls:C0011854 | Diabetes Mellitus, Type 1 | 5 | Biomarker |
umls:C0033860 | Psoriasis | 5 | Biomarker |
umls:C0024121 | Lung Neoplasms | 2 | Biomarker |
umls:C0040053 | Thrombosis | 2 | Biomarker |
umls:C0011884 | Diabetic Retinopathy | 2 | Biomarker |
umls:C0025289 | Meningitis | 2 | Biomarker |
umls:C0027059 | Myocarditis | 2 | Biomarker |
umls:C0003469 | Anxiety Disorders | 1 | Biomarker |
umls:C0993582 | Arthritis, Experimental | 1 | Biomarker |
umls:C0020503 | Hyperparathyroidism, Secondary | 1 | Biomarker |
umls:C0020557 | Hypertriglyceridemia | 1 | Therapeutic |
umls:C0023281 | Leishmaniasis | 1 | Biomarker |
umls:C0023290 | Leishmaniasis, Visceral | 1 | Biomarker |
umls:C0027707 | Nephritis, Interstitial | 1 | Biomarker |
umls:C0085397 | Pasteurellaceae Infections | 1 | Biomarker |
umls:C0038587 | Substance Withdrawal Syndrome | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for CRP |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Gene-centered drug-gene interaction network |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Experimental | DB03945 | Phosphocholine | Small molecule | |
Investigational | DB05744 | CRx-139 | Small molecule |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of CRP go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
Top |
Conservation information for LBS of CRP |
Multiple alignments for P02741 in multiple species |
LBS | AA sequence | # species | Species | D158 | LGQEQDSFGGN | 1 | Homo sapiens | D158 | LGQEQDSYGGG | 1 | Rattus norvegicus | D158 | LGQEQDSYGGD | 1 | Mus musculus | D78 | ATKRQDNEILI | 1 | Homo sapiens | D78 | ATKTSFNEILL | 1 | Rattus norvegicus | D78 | ATKKNSNDILI | 1 | Mus musculus | E156 | IILGQEQDSYG | 2 | Rattus norvegicus, Mus musculus | E156 | IILGQEQDSFG | 1 | Homo sapiens | E165 | FGGNFEGSQSL | 1 | Homo sapiens | E165 | YGGGFDANQSL | 1 | Rattus norvegicus | E165 | YGGDFDAKQSL | 1 | Mus musculus | E99 | TVGGSEILFEV | 1 | Homo sapiens | E99 | AVGGPEILFSA | 1 | Rattus norvegicus | E99 | GVGGAEVRFMV | 1 | Mus musculus | F164 | SFGGNFEGSQS | 1 | Homo sapiens | F164 | SYGGGFDANQS | 1 | Rattus norvegicus | F164 | SYGGDFDAKQS | 1 | Mus musculus | F84 | NEILIFWSKDI | 1 | Homo sapiens | F84 | NEILLFWTRGQ | 1 | Rattus norvegicus | F84 | NDILIFWNKDK | 1 | Mus musculus | L82 | QDNEILIFWSK | 1 | Homo sapiens | L82 | SFNEILLFWTR | 1 | Rattus norvegicus | L82 | NSNDILIFWNK | 1 | Mus musculus | N163 | DSFGGNFEGSQ | 1 | Homo sapiens | N163 | DSYGGGFDANQ | 1 | Rattus norvegicus | N163 | DSYGGDFDAKQ | 1 | Mus musculus | N79 | TKRQDNEILIF | 1 | Homo sapiens | N79 | TKTSFNEILLF | 1 | Rattus norvegicus | N79 | TKKNSNDILIF | 1 | Mus musculus | Q157 | ILGQEQDSYGG | 2 | Rattus norvegicus, Mus musculus | Q157 | ILGQEQDSFGG | 1 | Homo sapiens | Q168 | NFEGSQSLVGD | 1 | Homo sapiens | Q168 | GFDANQSLVGD | 1 | Rattus norvegicus | Q168 | DFDAKQSLVGD | 1 | Mus musculus | S92 | KDIGYSFTVGG | 1 | Homo sapiens | S92 | RGQGFSIAVGG | 1 | Rattus norvegicus | S92 | KDKQYTFGVGG | 1 | Mus musculus |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |